Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 200Thoracic 112CNS 106Breast 90Gynecologic 87Genitourinary 54Sarcoma 50Dermatologic 20Tumor-Agnostic 14Lymphoid 12Head & Neck 12Endocrine 7Other solid neoplasm 5Other hematologic neoplasm 5Plasma cell 3NET 3Myeloid 1Classical hematology 1

Conditions

Neoplasms 1Myeloproliferative Disorders 1Carcinoma, Transitional Cell 1

Interventions

fludarabine phosphate 113Cyclophosphamide 97Whole-Body Irradiation 82Mycophenolic Acid 79fludarabine 74Tacrolimus 69Busulfan 68Azacitidine 62Peripheral Blood Stem Cell Transplantation 59Melphalan 48Cytarabine 48Antilymphocyte Serum 47Methotrexate 45Cyclosporine 45Filgrastim 39Imatinib Mesylate 37Granulocyte Colony-Stimulating Factor 37Decitabine 35nilotinib 34thymoglobulin 31ruxolitinib 29Thiotepa 27Stem Cell Transplantation 23Clofarabine 22Alemtuzumab 21Rituximab 19Dasatinib 19Cord Blood Stem Cell Transplantation 19sargramostim 17Sirolimus 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Bevacizumab × Myeloid × Clear all
NCT00588666 2016-01-22

Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
51 enrolled 7 charts
GenitourinaryMyeloid

Carcinoma, Transitional Cell, Myeloproliferative Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡